| Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra bmj 371, 2020 | 804 | 2020 |
| Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques PD Yadav, R Ella, S Kumar, DR Patil, S Mohandas, AM Shete, ... Nature communications 12 (1), 1386, 2021 | 93 | 2021 |
| Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients GR Deshpande, GN Sapkal, BN Tilekar, PD Yadav, Y Gurav, S Gaikwad, ... Indian Journal of Medical Research 152 (1-2), 82-87, 2020 | 77 | 2020 |
| Suppl-2, M8: Japanese encephalitis: A brief review on Indian perspectives R Kulkarni, GN Sapkal, H Kaushal, DT Mourya The open virology journal 12, 121, 2018 | 73 | 2018 |
| Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG G Sapkal, A Shete-Aich, R Jain, PD Yadav, P Sarkale, R Lakra, ... Indian Journal of Medical Research 151 (5), 444-449, 2020 | 71 | 2020 |
| Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study V Ramesh, H Kaushal, AK Mishra, R Singh, P Salotra BMC public health 15, 1-8, 2015 | 64 | 2015 |
| Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals H Kaushal, R Bras-Gonçalves, NS Negi, JL Lemesre, G Papierok, ... BMC Infectious Diseases 14, 1-7, 2014 | 57 | 2014 |
| In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis R Chamakh-Ayari, R Bras-Gonçalves, N Bahi-Jaber, E Petitdidier, ... PloS one 9 (5), e92708, 2014 | 51 | 2014 |
| Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica GK Katara, A Raj, R Kumar, K Avishek, H Kaushal, NA Ansari, RA Bumb, ... BMC immunology 14, 1-9, 2013 | 46 | 2013 |
| Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India V Potdar, SS Cherian, GR Deshpande, PT Ullas, PD Yadav, ... Indian Journal of Medical Research 151 (2-3), 255-260, 2020 | 43 | 2020 |
| Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection AS Tripathy, S Vishwakarma, D Trimbake, YK Gurav, VA Potdar, ... Archives of Virology 166, 3301-3310, 2021 | 41 | 2021 |
| Case report: A patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India K Khandelwal, RA Bumb, RD Mehta, H Kaushal, C Lezama-Davila, ... The American journal of tropical medicine and hygiene 85 (1), 64, 2011 | 33 | 2011 |
| Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs K Avishek, H Kaushal, S Gannavaram, R Dey, A Selvapandiyan, ... Scientific reports 6 (1), 33059, 2016 | 30 | 2016 |
| Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection S Mohandas, R Jain, PD Yadav, A Shete-Aich, P Sarkale, M Kadam, ... Indian Journal of Medical Research 151 (5), 479-482, 2020 | 26 | 2020 |
| Heat, Oriental sore, and HIV N Prasad, BC Ghiya, RA Bumb, H Kaushal, AA Saboskar, ... The Lancet 377 (9765), 610, 2011 | 24 | 2011 |
| Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial JJ Mammen, S Kumar, L Thomas, G Kumar, A Zachariah, L Jeyaseelan, ... BMJ open 11 (10), e050571, 2021 | 23 | 2021 |
| Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in rhesus macaques P Yadav, R Ella, S Kumar, D Patil, S Mohandas, A Shete, G Bhati, ... | 23 | 2020 |
| Evaluation of cellular immunological responses in mono-and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India H Kaushal, R Bras-Gonçalves, K Avishek, D Kumar Deep, E Petitdidier, ... Clinical & Experimental Immunology 185 (1), 50-60, 2016 | 21 | 2016 |
| Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin R Kant, G Dwivedi, K Zaman, RR Sahay, G Sapkal, H Kaushal, ... Journal of Travel Medicine 28 (8), taab166, 2021 | 19 | 2021 |
| Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection PD Yadav, S Kumar, K Agarwal, M Jain, DR Patil, K Maithal, B Mathapati, ... BioRxiv, 2021.02. 02.429480, 2021 | 18 | 2021 |
Ruchi SinghICMR - National Institute of PathologyVerified email at icmr.org.in
